Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
The global Biological Excipient market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biological Excipient is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biological Excipient is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Biological Excipient include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biological Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Excipient.
Report Scope
The Biological Excipient market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biological Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Biological Excipient 麻豆原创 Overview
1.1 Product Overview and Scope of Biological Excipient
1.2 Biological Excipient Segment by Type
1.2.1 Global Biological Excipient 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Topical
1.3 Biological Excipient Segment by Application
1.3.1 Global Biological Excipient 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Biological Excipient 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Biological Excipient Revenue 2019-2030
1.4.2 Global Biological Excipient Sales 2019-2030
1.4.3 Global Biological Excipient 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biological Excipient 麻豆原创 Competition by Manufacturers
2.1 Global Biological Excipient Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Biological Excipient Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Biological Excipient Average Price by Manufacturers (2019-2024)
2.4 Global Biological Excipient Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Excipient, Product Type & Application
2.7 Biological Excipient 麻豆原创 Competitive Situation and Trends
2.7.1 Biological Excipient 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biological Excipient Players 麻豆原创 Share by Revenue
2.7.3 Global Biological Excipient 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Excipient Retrospective 麻豆原创 Scenario by Region
3.1 Global Biological Excipient 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biological Excipient Global Biological Excipient Sales by Region: 2019-2030
3.2.1 Global Biological Excipient Sales by Region: 2019-2024
3.2.2 Global Biological Excipient Sales by Region: 2025-2030
3.3 Global Biological Excipient Global Biological Excipient Revenue by Region: 2019-2030
3.3.1 Global Biological Excipient Revenue by Region: 2019-2024
3.3.2 Global Biological Excipient Revenue by Region: 2025-2030
3.4 North America Biological Excipient 麻豆原创 Facts & Figures by Country
3.4.1 North America Biological Excipient 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biological Excipient Sales by Country (2019-2030)
3.4.3 North America Biological Excipient Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Excipient 麻豆原创 Facts & Figures by Country
3.5.1 Europe Biological Excipient 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biological Excipient Sales by Country (2019-2030)
3.5.3 Europe Biological Excipient Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Excipient 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Biological Excipient 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biological Excipient Sales by Country (2019-2030)
3.6.3 Asia Pacific Biological Excipient Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biological Excipient 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Biological Excipient 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biological Excipient Sales by Country (2019-2030)
3.7.3 Latin America Biological Excipient Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Excipient 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Biological Excipient 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biological Excipient Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biological Excipient Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Excipient Sales by Type (2019-2030)
4.1.1 Global Biological Excipient Sales by Type (2019-2024)
4.1.2 Global Biological Excipient Sales by Type (2025-2030)
4.1.3 Global Biological Excipient Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Biological Excipient Revenue by Type (2019-2030)
4.2.1 Global Biological Excipient Revenue by Type (2019-2024)
4.2.2 Global Biological Excipient Revenue by Type (2025-2030)
4.2.3 Global Biological Excipient Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Biological Excipient Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biological Excipient Sales by Application (2019-2030)
5.1.1 Global Biological Excipient Sales by Application (2019-2024)
5.1.2 Global Biological Excipient Sales by Application (2025-2030)
5.1.3 Global Biological Excipient Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Biological Excipient Revenue by Application (2019-2030)
5.2.1 Global Biological Excipient Revenue by Application (2019-2024)
5.2.2 Global Biological Excipient Revenue by Application (2025-2030)
5.2.3 Global Biological Excipient Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Biological Excipient Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ashland Inc.
6.1.1 Ashland Inc. Corporation Information
6.1.2 Ashland Inc. Description and Business Overview
6.1.3 Ashland Inc. Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ashland Inc. Biological Excipient Product Portfolio
6.1.5 Ashland Inc. Recent Developments/Updates
6.2 BASF Corporation
6.2.1 BASF Corporation Corporation Information
6.2.2 BASF Corporation Description and Business Overview
6.2.3 BASF Corporation Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BASF Corporation Biological Excipient Product Portfolio
6.2.5 BASF Corporation Recent Developments/Updates
6.3 Colorcon Inc.
6.3.1 Colorcon Inc. Corporation Information
6.3.2 Colorcon Inc. Description and Business Overview
6.3.3 Colorcon Inc. Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Colorcon Inc. Biological Excipient Product Portfolio
6.3.5 Colorcon Inc. Recent Developments/Updates
6.4 Evonik Industries
6.4.1 Evonik Industries Corporation Information
6.4.2 Evonik Industries Description and Business Overview
6.4.3 Evonik Industries Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evonik Industries Biological Excipient Product Portfolio
6.4.5 Evonik Industries Recent Developments/Updates
6.5 FMC Corporation
6.5.1 FMC Corporation Corporation Information
6.5.2 FMC Corporation Description and Business Overview
6.5.3 FMC Corporation Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.5.4 FMC Corporation Biological Excipient Product Portfolio
6.5.5 FMC Corporation Recent Developments/Updates
6.6 The Archer Daniels Midland Company
6.6.1 The Archer Daniels Midland Company Corporation Information
6.6.2 The Archer Daniels Midland Company Description and Business Overview
6.6.3 The Archer Daniels Midland Company Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.6.4 The Archer Daniels Midland Company Biological Excipient Product Portfolio
6.6.5 The Archer Daniels Midland Company Recent Developments/Updates
6.7 The Dow Chemical Company
6.6.1 The Dow Chemical Company Corporation Information
6.6.2 The Dow Chemical Company Description and Business Overview
6.6.3 The Dow Chemical Company Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 The Dow Chemical Company Biological Excipient Product Portfolio
6.7.5 The Dow Chemical Company Recent Developments/Updates
6.8 Wacker Chemie AG.
6.8.1 Wacker Chemie AG. Corporation Information
6.8.2 Wacker Chemie AG. Description and Business Overview
6.8.3 Wacker Chemie AG. Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wacker Chemie AG. Biological Excipient Product Portfolio
6.8.5 Wacker Chemie AG. Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Corporation Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck KGaA Biological Excipient Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 Colorcon
6.10.1 Colorcon Corporation Information
6.10.2 Colorcon Description and Business Overview
6.10.3 Colorcon Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Colorcon Biological Excipient Product Portfolio
6.10.5 Colorcon Recent Developments/Updates
6.11 Associated British Foods plc
6.11.1 Associated British Foods plc Corporation Information
6.11.2 Associated British Foods plc Biological Excipient Description and Business Overview
6.11.3 Associated British Foods plc Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Associated British Foods plc Biological Excipient Product Portfolio
6.11.5 Associated British Foods plc Recent Developments/Updates
6.12 Signet Excipients Pvt. Ltd (IMCD)
6.12.1 Signet Excipients Pvt. Ltd (IMCD) Corporation Information
6.12.2 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Description and Business Overview
6.12.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Portfolio
6.12.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments/Updates
6.13 Sigachi Industries Limited
6.13.1 Sigachi Industries Limited Corporation Information
6.13.2 Sigachi Industries Limited Biological Excipient Description and Business Overview
6.13.3 Sigachi Industries Limited Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sigachi Industries Limited Biological Excipient Product Portfolio
6.13.5 Sigachi Industries Limited Recent Developments/Updates
6.14 Spectrum Chemical Manufacturing Corp.
6.14.1 Spectrum Chemical Manufacturing Corp. Corporation Information
6.14.2 Spectrum Chemical Manufacturing Corp. Biological Excipient Description and Business Overview
6.14.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Portfolio
6.14.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
6.15 IMCD
6.15.1 IMCD Corporation Information
6.15.2 IMCD Biological Excipient Description and Business Overview
6.15.3 IMCD Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.15.4 IMCD Biological Excipient Product Portfolio
6.15.5 IMCD Recent Developments/Updates
6.16 Clariant
6.16.1 Clariant Corporation Information
6.16.2 Clariant Biological Excipient Description and Business Overview
6.16.3 Clariant Biological Excipient Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Clariant Biological Excipient Product Portfolio
6.16.5 Clariant Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Excipient Industry Chain Analysis
7.2 Biological Excipient Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Excipient Production Mode & Process
7.4 Biological Excipient Sales and 麻豆原创ing
7.4.1 Biological Excipient Sales Channels
7.4.2 Biological Excipient Distributors
7.5 Biological Excipient Customers
8 Biological Excipient 麻豆原创 Dynamics
8.1 Biological Excipient Industry Trends
8.2 Biological Excipient 麻豆原创 Drivers
8.3 Biological Excipient 麻豆原创 Challenges
8.4 Biological Excipient 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
听
听
*If Applicable.